Natera’s Heart Test Can Better Detect Rejection for Transplant Patients
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
Read MorePosted by Andy Lundin | Jun 17, 2024 | Transfusion & Transplantation Tests |
Natera launched Prospera Heart with Donor Quantity Score, enhancing its ability to detect rejection in heart transplant patients.
Read MorePosted by Chris Wolski | Jun 17, 2024 | Emerging & Zoonotic Diseases |
H5N1 avian flu, historically infecting birds, has recently infected three farm workers. Diagnostic testing may be our best defense.
Read MorePosted by Andy Lundin | Jun 17, 2024 | Company News |
MGI and SeqOne will collaborate to develop and validate comprehensive genomic analysis solutions for human genetics and pathology labs.
Read MorePosted by Andy Lundin | Jun 11, 2024 | Research |
Avalon Healthcare Solutions’ Lab Trend Report found the use of genetic testing increased last year, while routine testing remained stable.
Read MorePosted by Andy Lundin | Jun 5, 2024 | Cervical (HPV) |
Researchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
Read More